AU674895B2 - Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it - Google Patents

Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it Download PDF

Info

Publication number
AU674895B2
AU674895B2 AU52842/93A AU5284293A AU674895B2 AU 674895 B2 AU674895 B2 AU 674895B2 AU 52842/93 A AU52842/93 A AU 52842/93A AU 5284293 A AU5284293 A AU 5284293A AU 674895 B2 AU674895 B2 AU 674895B2
Authority
AU
Australia
Prior art keywords
solution according
document
line
solution
date
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
AU52842/93A
Other languages
English (en)
Other versions
AU5284293A (en
Inventor
Craig William Davis
Alison Green Floyd
Mary Sou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of AU5284293A publication Critical patent/AU5284293A/en
Application granted granted Critical
Publication of AU674895B2 publication Critical patent/AU674895B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/765Polymers containing oxygen
    • A61K31/77Polymers containing oxygen of oxiranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Packages (AREA)
AU52842/93A 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it Expired - Fee Related AU674895B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9221883 1992-10-19
GB929221883A GB9221883D0 (en) 1992-10-19 1992-10-19 Novel formulation
PCT/GB1993/002141 WO1994008596A1 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it

Publications (2)

Publication Number Publication Date
AU5284293A AU5284293A (en) 1994-05-09
AU674895B2 true AU674895B2 (en) 1997-01-16

Family

ID=10723654

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52842/93A Expired - Fee Related AU674895B2 (en) 1992-10-19 1993-10-18 Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it

Country Status (19)

Country Link
EP (1) EP0671919A1 (ja)
JP (1) JPH08502284A (ja)
KR (1) KR950703345A (ja)
AU (1) AU674895B2 (ja)
BR (1) BR9307268A (ja)
CA (1) CA2147889A1 (ja)
CZ (1) CZ63395A3 (ja)
GB (1) GB9221883D0 (ja)
HU (1) HUT75701A (ja)
IL (1) IL107313A0 (ja)
MX (1) MX9306467A (ja)
NO (1) NO951462L (ja)
NZ (1) NZ256890A (ja)
PL (1) PL308459A1 (ja)
SI (1) SI9300545A (ja)
SK (1) SK44795A3 (ja)
TW (1) TW276183B (ja)
WO (1) WO1994008596A1 (ja)
ZA (1) ZA937714B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2185162A4 (en) * 2007-08-10 2012-04-25 Synthrx Inc POLYMER THERAPY FOR THE TREATMENT OF CHRONIC MICROVASCULAR DISEASES
AU2014337190A1 (en) 2013-10-16 2016-06-02 Liferaft Biosciences, Inc. Diuretic induced alterations of plasma volume
WO2016007542A1 (en) 2014-07-07 2016-01-14 Mast Therapeutics, Inc. Poloxamer therapy for heart failure
AU2015287993B2 (en) 2014-07-07 2020-10-29 Liferaft Biosciences, Inc. A poloxamer composition free of long circulating material and methods for production and uses thereof
US9757411B2 (en) 2014-07-07 2017-09-12 Aires Pharmaceuticals, Inc. Poloxamer therapy for heart failure
CN109432511A (zh) * 2018-12-29 2019-03-08 常州乐奥医疗科技股份有限公司 一种温敏型水凝胶及其制备方法和用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641240A (en) * 1968-09-27 1972-02-08 Wyandotte Chemicals Corp Method for the treatment of an embolus or thrombus
DE3234084A1 (de) * 1982-09-14 1984-03-15 B. Braun Melsungen Ag, 3508 Melsungen Pharmazeutische zubereitungen zur behandlung von unerwuenschten verwachsungen sowie deren verwendung
US4879109A (en) * 1986-05-15 1989-11-07 Emory University Method for treating burns
US4938961A (en) * 1989-04-28 1990-07-03 Geoffrey Collins Organ preservation solution containing pokyethylene gycol and method of performing cardioplegia

Also Published As

Publication number Publication date
EP0671919A1 (en) 1995-09-20
WO1994008596A1 (en) 1994-04-28
NZ256890A (en) 1995-10-26
HU9501104D0 (en) 1995-06-28
AU5284293A (en) 1994-05-09
HUT75701A (en) 1997-05-28
TW276183B (ja) 1996-05-21
NO951462D0 (no) 1995-04-18
CZ63395A3 (en) 1995-07-12
PL308459A1 (en) 1995-07-24
CA2147889A1 (en) 1994-04-28
SK44795A3 (en) 1996-05-08
ZA937714B (en) 1995-04-18
JPH08502284A (ja) 1996-03-12
KR950703345A (ko) 1995-09-20
MX9306467A (es) 1994-05-31
SI9300545A (en) 1994-06-30
NO951462L (no) 1995-06-13
GB9221883D0 (en) 1992-12-02
IL107313A0 (en) 1994-01-25
BR9307268A (pt) 1999-05-11

Similar Documents

Publication Publication Date Title
KR100884711B1 (ko) 외용 투여용 올로파타딘 제제
KR100191873B1 (ko) 안정화된 pvp-i 용액
US20060127423A1 (en) Organic compounds
EP0095897A2 (en) Pharmaceutical formulations
US7432360B2 (en) Multi-dose erythropoietin formulations
US6214866B1 (en) Composition comprising mupirocin and chlorhexidine
AU674895B2 (en) Composition based on polyoxyethylene-polyoxypropylene block copolymers and container containing it
KR100760326B1 (ko) 카르밤아제핀 또는 그의 유도체를 포함하는 비경구 제형
US4973591A (en) Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
US11166911B2 (en) Parenteral dosage form of amiodarone
US5063220A (en) Parenteral formulations of 1-diphenylmethyl-4-((2-(4-methylphenyl)-5-methyl-1H-imidazol-4-yl)methyl)piperazine
EP1800664B1 (en) Pharmaceutical formulations for parenteral administration comprising epothilone
MXPA00003413A (en) Parenteral formulations comprising carbamazepine or its derivatives
MXPA99001136A (en) Composition comprising mupirocin and chlorhexidine
MXPA02000804A (en) Multi dose erythropoietin formulations